U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
U.S. Physical Therapy Price Performance
USPH stock opened at $91.87 on Thursday. The business’s 50-day moving average is $84.02 and its two-hundred day moving average is $91.26. The firm has a market capitalization of $1.39 billion, a P/E ratio of 97.73, a P/E/G ratio of 4.16 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. U.S. Physical Therapy’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.76 EPS. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after acquiring an additional 956 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in shares of U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Quantbot Technologies LP lifted its position in U.S. Physical Therapy by 57.6% during the 3rd quarter. Quantbot Technologies LP now owns 10,876 shares of the company’s stock worth $920,000 after acquiring an additional 3,973 shares in the last quarter. Intech Investment Management LLC purchased a new position in U.S. Physical Therapy in the 3rd quarter worth approximately $356,000. Finally, First Horizon Advisors Inc. lifted its holdings in U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after buying an additional 298 shares in the last quarter.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on USPH shares. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America reaffirmed a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, Barrington Research reiterated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.
View Our Latest Stock Analysis on U.S. Physical Therapy
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- How to Invest in Blue Chip Stocks
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Tariff Troubles: 3 Stocks Planning Higher Prices
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.